2020 Korean Consensus Guidelines for Diagnosis and Treatment of Chronic Hand Eczema

키워드

참고문헌 (62)

1. Diepgen TL, "Guidelines for diagnosis, prevention and treatment of hand eczema", J Dtsch Dermatol Ges, 13, pp.e1~e22 (2015)
2. James WD, "Andrews’ diseases of the skin: clinical dermatology", pp.63~91 (2019), Elsevier
3. Veien NK, "Hand eczema: causes, course, and prognosis II", Contact Dermatitis, 58, pp.335~339 (2008)
4. 박재범, "Clinical Features and Awareness of Hand Eczema in Korea", Annals of Dermatology, 28(3), pp.335~343 (2016), 대한피부과학회
5. Thyssen JP, "The epidemiology of hand eczema in the general population--prevalence and main findings", Contact Dermatitis, 62, pp.75~87 (2010)
6. English J, "Consensus statement on the management of chronic hand eczema", Clin Exp Dermatol, 34, pp.761~769 (2009)
7. Darlenski R, "Influence of skin type, race, sex, and anatomic location on epidermal barrier function", Clin Dermatol, 30, pp.269~273 (2012)
8. Meding B, "Differences between the sexes with regard to work-related skin disease", Contact Dermatitis, 43, pp.65~71 (2000)
9. Ruzicka T, "Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial", Br J Dermatol, 158, pp.808~817 (2008)
10. Coenraads PJ, "Construction and validation of a photographic guide for assessing severity of chronic hand dermatitis", Br J Dermatol, 152, pp.296~301 (2005)
11. Cvetkovski RS, "Relation between diagnoses on severity, sick leave and loss of job among patients with occupational hand eczema", Br J Dermatol, 152, pp.93~98 (2005)
12. Bissonnette R, "Redefining treatment options in chronic hand eczema (CHE)", J Eur Acad Dermatol Venereol, 24(Suppl 3), pp.1~20 (2010)
13. Diepgen TL, "Management of chronic hand eczema", Contact Dermatitis, 57, pp.203~210 (2007)
14. Agner T, "Classification of hand eczema", J Eur Acad Dermatol Venereol, 29, pp.2417~2422 (2015)
15. Diepgen TL, "Guideline on the management of hand eczema ICD-10 Code: L20. L23. L24. L25. L30", J Dtsch Dermatol Ges, 7(Suppl 3), pp.S1~S16 (2009)
16. Menné T, "Hand eczema guidelines based on the Danish guidelines for the diagnosis and treatment of hand eczema", Contact Dermatitis, 65, pp.3~12 (2011)
17. Wollersheim H, "Clinical guidelines to improve patient care", Neth J Med, 63, pp.188~192 (2005)
18. Nedorost ST, "Fitzpatrick's dermatology", pp.414~427 (2019), McGraw Hill Education
19. Bandier J, "Skin reaction and regeneration after single sodium lauryl sulfate exposure stratified by filaggrin genotype and atopic dermatitis phenotype", Br J Dermatol, 172, pp.1519~1529 (2015)
20. Palmer CN, "Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis", Nat Genet, 38, pp.441~446 (2006)
21. Hersle K, "Hyperkeratotic dermatitis of the palms", Br J Dermatol, 107, pp.195~201 (1982)
22. Baden HP, "Treatment of hyperkeratotic dermatitis of the palms. Sequential treatment with a keratolytic gel and corticosteroid ointment", Arch Dermatol, 110, pp.737~738 (1974)
23. Cohen DE, "Dermatology", pp.262~273 (2018), Elsevier
24. Mernelius S, "Staphylococcus aureus colonization related to severity of hand eczema", Eur J Clin Microbiol Infect Dis, 35, pp.1355~1361 (2016)
25. Nørreslet LB, "Colonization with Staphylococcus aureus in patients with hand eczema: Prevalence and association with severity, atopic dermatitis, subtype and nasal colonization", Contact Dermatitis, 83, pp.442~449 (2020)
26. Christoffers WA, "Interventions for hand eczema", Cochrane Database Syst Rev, 4, pp.CD004055~ (2019)
27. "Efficacy and Safety of Dupilumab Chronic Hands Eczema Refractory to Highly Potent Topical Corticosteroids (DUPECZEMAIN)" (2019)[URL]
28. Yang J, "Assessing the short-term efficacy and safety of guselkumab for moderate-to-severe plaque psoriasis: meta-analysis of randomized controlled trials", J Immunol Res, 2020, pp.4975628~ (2020)
29. Terui T, "Efficacy and safety of guselkumab, an antiinterleukin 23 monoclonal antibody, for palmoplantar pustulosis: a randomized clinical trial", JAMA Dermatol, 154, pp.309~316 (2018)
30. Held E, "Effect of different moisturizers on SLS-irritated human skin", Contact Dermatitis, 44, pp.229~234 (2001)
31. Korinth G, "In vitro evaluation of the efficacy of skin barrier creams and protective gloves on percutaneous absorption of industrial solvents", Int Arch Occup Environ Health, 76, pp.382~386 (2003)
32. Fartasch M, "Wet work and barrier function", Curr Probl Dermatol, 49, pp.144~151 (2016)
33. Ramsing DW, "Effect of glove occlusion on human skin (II). Long-term experimental exposure", Contact Dermatitis, 34, pp.258~262 (1996)
34. Ramsing DW, "Effect of glove occlusion on human skin. (I). short-term experimental exposure", Contact Dermatitis, 34, pp.1~5 (1996)
35. Nixon RL, "Dermatology", pp.242~261 (2018), Elsevier
36. Soost S, "Topical therapy of hand eczema-analysis of the prescription profile from dermatologists in private practice", J Dtsch Dermatol Ges, 10, pp.180~184 (2012)
37. Kao JS, "Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity : inhibition of epidermal lipid synthesis accounts for functional abnormalities", J Invest Dermatol, 120, pp.456~464 (2003)
38. Ale IS, "Irritant contact dermatitis", Rev Environ Health, 29, pp.195~206 (2014)
39. Baeck M, "Immediate and delayed allergic hypersensitivity to corticosteroids: practical guidelines", Contact Dermatitis, 66, pp.38~45 (2012)
40. Schnopp C, "Topical tacrolimus (FK506) and mometasone furoate in treatment of dyshidrotic palmar eczema: a randomized, observer-blinded trial", Am Acad Dermatol, 46, pp.73~77 (2002)
41. 권형일, "Efficacy and Safety of Alitretinoin for Chronic Hand Eczema in Korean Patients", Annals of Dermatology, 28(3), pp.364~370 (2016), 대한피부과학회
42. Kim HJ, "Use of alitretinoin in moderate to severe chronic hand eczema: a real-world experience in Korea", Dermatol Ther, 32, pp.e12980~ (2019)
43. Irla N, "Alitretinoin abrogates innate inflammation in palmoplantar pustular psoriasis", Br J Dermatol, 167, pp.1170~1174 (2012)
44. Kumari V, "Impact of systemic alitretinoin treatment on skin barrier gene and protein expression in patients with chronic hand eczema", Br J Dermatol, 175, pp.1243~1250 (2016)
45. Cheon DU, "Efficacy of alitretinoin depending on the concomitant use of topical corticosteroids in chronic hand eczema patients", J Dermatol, 46, pp.998~1005 (2019)
46. Bissonnette R, "Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema", Br J Dermatol, 162, pp.420~426 (2010)
47. 이지수, "Efficacy and Safety of Oral Alitretinoin in Hand Eczema and Palmoplantar Pustulosis in Korean Patients", Annals of Dermatology, 31(2), pp.139~145 (2019), 대한피부과학회[DOI]
48. Jankowska-Konsur A, "Systemic antihistamines--a common outside the guidelines therapeutic strategy in hand eczema management", J Eur Acad Dermatol Venereol, 30, pp.67~71 (2016)
49. Granlund H, "Comparison of cyclosporine and topical betamethasone-17,21-dipropionate in the treatment of severe chronic hand eczema", Acta Derm Venereol, 76, pp.371~376 (1996)
50. Granlund H, "Long-term follow-up of eczema patients treated with cyclosporine", Acta Derm Venereol, 78, pp.40~43 (1998)
51. Thestrup-Pedersen K, "Treatment of hyperkeratotic dermatitis of the palms (eczema keratoticum) with oral acitretin. A single-blind placebocontrolled study", Acta Derm Venereol, 81, pp.353~355 (2001)
52. Egan CA, "Low-dose oral methotrexate treatment for recalcitrant palmoplantar pompholyx", J Am Acad Dermatol, 40, pp.612~614 (1999)
53. Shah RA, "Brief update on dermatologic uses of methotrexate", Skin Therapy Lett, 24, pp.5~8 (2019)
54. Brass D, "An observer-blinded randomized controlled pilot trial comparing localized immersion psoralen-ultraviolet A with localized narrowband ultraviolet B for the treatment of palmar hand eczema", Br J Dermatol, 179, pp.63~71 (2018)
55. Sjövall P, "Treatment of chronic hand eczema with UV-B Handylux in the clinic and at home", Contact Dermatitis, 31, pp.5~8 (1994)
56. Juntongjin P, "Synergistic effects of the 308-nm excimer light and topical calcipotriol for the treatment of chronic hand eczema : a randomized controlled study", Dermatology, 237, pp.31~38 (2021)
57. Shroff A, "Use of 308 nm excimer laser for the treatment of chronic hand and foot eczema", Int J Dermatol, 55, pp.e447~e453 (2016)
58. Agner T, "Comparison of four methods for assessment of severity of hand eczema", Contact Dermatitis, 69, pp.107~111 (2013)
59. Hald M, "Severity of hand eczema assessed by patients and dermatologist using a photographic guide", Br J Dermatol, 156, pp.77~80 (2007)
60. Held E, "The hand eczema severity index (HECSI): a scoring system for clinical assessment of hand eczema. A study of inter- and intraobserver reliability", Br J Dermatol, 152, pp.302~307 (2005)
61. Simons JR, "A left-right comparison of UVB phototherapy and topical photochemotherapy in bilateral chronic hand dermatitis after 6 weeks’ treatment", Clin Exp Dermatol, 22, pp.7~10 (1997)
62. Van Der Valk PG, "A simple tool with which to study the course of chronic hand eczema in clinical practice : a reduced-item score", Contact Dermatitis, 69, pp.112~117 (2013)

관련 논문AI추천